Join experts from RMP, QIPCM, JDMI and CanProbe in a short workshop on CXCL12/CXCR4 imaging on April 18.
If you’re not familiar with the acronym, it’s a pathway involved in cancer and cardiovascular disease, and Positron Emission Tomography (PET) markers have been developed that can image activity in this pathway. PET/CT and PET/MR imaging with new CXCR4 probes can power studies on cancer progression, treatment response, and more.
This workshop will help introduce this new way of imaging, and gauge interest from the community to determine whether CanProbe should invest in producing CXCR4 agents at UHN’s cyclotron facility. Experts from QIPCM, our imaging core lab facility, will be on hand to help you design your imaging-based study.
April 18, 9am-10:30am, 700 University Ave. (OPG Building), Rm 6-114 Toronto, ON. Please see this flyer for more details.